The authors wish to make a correction to the published version of their paper [1], having detected a minor error in Table 2. A corrected version of the table appears below, in which absolute values for the large (LAC) and small (SAC) artery compliance have been replaced with the treatment difference values. We apologize for this change which has no impact on the scientific outcomes or conclusions of the study. The original manuscript will remain online on the article webpage, with reference to this correction.
Table 2.
Treatment differences in the measures of arterial function for placebo and LCn-3PUFA groups.
| All Participants | Males | Females | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Placebo | LCn-3PUFA | p | Placebo (n = 13) | LCn-3PUFA (n = 13) | p | Placebo (n = 6) | LCn-3PUFA (n = 6) | p | |
| Systolic BP (mmHg) | −3.1 ± 0.4 | −5.0 ± 2.2 | 0.43 | −4.1 ± 0.4 | −5.3 ± 2.5 | 0.90 | 0.1 ± 0.7 | −4.2 ± 2.7 | 0.52 |
| Diastolic BP (mmHg) | −1.3 ± 1.2 | −4.5 ± 1.1 | 0.12 | −2.7 ± 1.8 | −8.7 ± 2.2 | 0.42 | 6.9 ± 1.6 | −4.6 ± 1.4 | 0.20 |
| LAC (mL/mmHg ×10) | 2.4 ± 0.9 | 2.3 ± 0.8 | 0.96 | 3.4 ± 1.3 | 2.8 ± 0.9 | 0.73 | 1.0 ± 1.3 | 1.2 ± 0.8 | 0.93 |
| SAC (mL/mmHg ×100) | 0.2 ± 0.3 | 0.4 ± 0.3 | 0.62 | 0.3 ± 0.5 | 0.4 ± 0.4 | 0.90 | -0.1 ± 0.1 | 0.3 ± 0.3 | 0.20 |
| SVR * (dyne·s·cm−5) | −28.3 ± 25.2 | −125.2 ± 22.1 | 0.05 | −83.6 ± 30.2 | −153.2 ± 33.1 | 0.4 | 39.1 ± 35.2 | −100.1 ± 32.1 | 0.08 |
| MBFV | −0.5 ± -2.7 | −4.8 ± 2.1 | 0.27 | 1.7 ± 2.7 | −7.6 ± 4.3 | 0.07 | −4.1 ± 4.4 | −2.3 ± 4.6 | 0.51 |
| PI * | 0.02 ± 0.04 | −0.03 ± 0.05 | 0.02 | −0.04 ± 0.04 | −0.00 ± 0.03 | 0.30 | 0.23 ± 0.02 | −0.09 ± 0.04 | 0.05 |
See Table 1 for abbreviations. * A more negative value indicates a reduction in resistance/stiffness.
Reference
- 1.Howe P.R.C., Kuszewski J.C., Wong R.H.X. Effects of long-chain omega-3 polyunsaturated fatty acids on brain function in mildly hypertensive older adults. Nutrients. 2018;10:1413. doi: 10.3390/nu10101413. [DOI] [PMC free article] [PubMed] [Google Scholar]
